###
中国临床研究:2022,35(10):1415-1419
本文二维码信息
码上扫一扫!
甲状腺未分化癌23例预后分析
(重庆大学附属肿瘤医院头颈肿瘤中心,重庆 400030)
Prognostic analysis of 23 cases of anaplastic thyroid carcinoma
(Head and Neck Cancer Center, Chongqing University Cancer Hospital, Chongqing 400030, China)
摘要
本文已被:浏览 447次   下载 278
投稿时间:2022-04-07   网络发布日期:2022-10-20
中文摘要: 目的 探讨甲状腺未分化癌的临床特征及治疗方式与预后的关系。 方法 回顾性分析重庆大学附属肿瘤医院2012年3月至2019年9月收治的23例甲状腺未分化癌患者的临床及随访资料。 结果 23例甲状腺未分化癌患者中位生存时间15周,3个月生存率56.5%,6个月生存率39.1%,12个月生存率30.4%。单因素分析显示,入院时血小板是否正常、纤维蛋白原水平、综合治疗模式是甲状腺未分化癌生存时间的影响因素(P<0.05,P<0.01)。多因素分析显示,放疗剂量≥50 Gy、病灶R0或R1切除+放疗≥50 Gy是影响甲状腺未分化癌生存预后的有利因素(P<0.01,P<0.05)。 结论 甲状腺未分化癌恶性程度极高,对有手术机会的患者尽量采取颈部病灶R0或R1切除+放疗的治疗模式,对已失去手术机会的患者采取放疗也有可能获得相近疗效。
Abstract:ObjectiveTo investigate the associations of clinical features and treatment with prognosis of anaplastic thyroid carcinoma(ATC). Methods The clinical and follow-up data of 23 ATC patients admitted to Chongqing University Cancer Hospital from March 2012 to September 2019 were retrospectively analyzed. Results The median survival time of 23 ATC patients was 15 weeks. The 3-month survival rate, the 6-month survival rate and the 12-month survival rate were 56.5%, 39.1% and 30.4%,respectively. Univariate analysis showed that platelet count at admission, fibrinogen level and comprehensive treatment mode were the factors affecting the survival time of ATC patients(P<0.05, P<0.01). Multivariate analysis showed that radiotherapy doses≥50 Gy, R0 or R1 resection+radiotherapy≥50 Gy were the favorable factors affecting survival outcome of ATC patients(P<0.01,P<0.05). Conclusion The degree of malignancy of ATC is extremely high. R0 or R1 resection plus radiotherapy should be adopted as far as possible for ATC patients who have the opportunity of surgery. Radiotherapy may also achieve the similar effect for patients who have lost the opportunity of surgery.
文章编号:     中图分类号:R736.1    文献标志码:B
基金项目:重庆市沙坪坝区决策咨询与管理创新项目(Jcd202120)
引用文本:
叶果,陈瑜,杨鑫.甲状腺未分化癌23例预后分析[J].中国临床研究,2022,35(10):1415-1419.

用微信扫一扫

用微信扫一扫